𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Botulinum toxin in cervical dystonia: low dosage with electromyographic guidance

✍ Scribed by J. W. M. Brans; I. P. Boer; M. Aramideh; J. D. Speelman; B. W. Ongerboer de Visser

Publisher
Springer
Year
1995
Tongue
English
Weight
495 KB
Volume
242
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of clinical rating scales in
Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin
✍ Dr. Daniel Tarsy 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB

## Abstract Seventy‐six consecutive patients with cervical dystonia (CD) treated with botulinum toxin were assessed with the Tsui rating scale, the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS), and a global scale of improvement. Tsui, TWSTRS, and TWSTRS subscale scores all showed sig

Long-term botulinum toxin treatment incr
Long-term botulinum toxin treatment increases employment rate in patients with cervical dystonia
✍ Inger Marie Skogseid; Jo Røislien; Bjørgulf Claussen; Emilia Kerty 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

## Abstract We examined the impact of cervical dystonia (CD) and long‐term botulinum toxin (BTX) treatment on employment status. Data on employment status at onset of CD, at initiation of BTX treatment, and at evaluation of long‐term treatment were obtained from 62 CD patients aged 31–66 years (med

Long-term treatment with botulinum toxin
Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay
✍ Mitchell F. Brin; Cynthia L. Comella; Joseph Jankovic; Francis Lai; Markus Nauma 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

## Abstract To evaluate the immunogenicity of botulinum toxin type A (BoNTA; BOTOX) in cervical dystonia (CD). Subjects diagnosed with CD for ≥1 year and previously naïve to BoNTs were treated with BoNTA in a prospective, open‐label, multicenter study. Serum samples were analyzed for BoNTA neutrali

Botulinum toxin type B vs. type A in tox
Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial
✍ Eric J. Pappert; Terry Germanson 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

## Abstract The objective of this study was to compare efficacy, safety, and duration of botulinum toxin type A (BoNT‐A) and type B (BoNT‐B) in toxin‐naïve cervical dystonia (CD) subjects. BoNT‐naïve CD subjects were randomized to BoNT‐A or BoNT‐B and evaluated in a double‐blind trial at baseline a